BNP and NT-proBNP: When Do They Actually Help Before Surgery?
BNP is a risk-refinement tool, not a diagnostic test for heart failure. Not every patient benefits from BNP measurement. Understanding when BNP changes perioperative decision-making is the key question.
Key points
- BNP reflects cardiac wall stress — sensitivity is high, specificity is low. It is not a diagnostic test for heart failure.
- BNP testing adds the most value in patients with intermediate-to-high surgical risk. In low-RCRI patients, it is unlikely to change management.
- Reference thresholds: BNP ≈92 pg/mL, NT-proBNP ≈300 pg/mL — these are perioperative risk thresholds, not diagnostic cutoffs.
- Elevated BNP should prompt evaluation of the cause, not automatic surgical delay or cardiology referral.
When to use this page
When deciding whether to measure BNP before surgery. When BNP is already elevated and you need to know what to do next. When the Navigator flags BNP as contributing to the integrated risk assessment.
What BNP measures — and what it does not
Key point
BNP is a perioperative risk signal, not a diagnostic test for heart failure. An elevated BNP cannot confirm heart failure, quantify ventricular function, or determine whether surgery should proceed. The relevant question is: why is BNP elevated?
BNP (B-type natriuretic peptide) is released when cardiac wall stress increases — from pressure load, volume load, or both. It is sensitive but not specific: many conditions beyond heart failure can elevate BNP, including valvular disease, atrial fibrillation, renal impairment, and age-related changes. This means an elevated BNP signals that cardiac stress may be present, but it cannot tell you why.
When does BNP add value?
Key point
BNP is most useful when the result can actually change perioperative management. In low-RCRI patients, BNP is unlikely to reclassify risk. The value of BNP increases when baseline risk is intermediate to high.
- Intermediate-to-high risk surgery planned (intraabdominal, vascular, thoracic)
- Elevated RCRI (≥1) with a need for further risk stratification
- Functional capacity unknown or difficult to assess reliably
- Cardiac disease suspected but not yet confirmed
Conversely, in patients with RCRI = 0 undergoing low-risk surgery, BNP measurement is unlikely to change management and is not routinely recommended (JCS 2022).
Perioperative reference thresholds
- BNP: ≈92 pg/mL (VISION trial; referenced in ESC 2022)
- NT-proBNP: ≈300 pg/mL (ESC 2022)
These are perioperative risk-stratification thresholds, not diagnostic cutoffs for heart failure. Values above these thresholds are associated with increased risk of postoperative major adverse cardiac events (MACE). Institutional thresholds may vary — always verify the reference range used at your institution.
What to do when BNP is elevated
- ① Assess symptoms: dyspnea, orthopnea, edema, reduced exercise tolerance
- ② Reassess functional capacity: confirm whether 4 METs can be achieved
- ③ Confirm RCRI factors: quantify the full risk factor burden
- ④ Review prior echocardiography if available
- ⑤ Obtain echocardiography if the cause is unclear — evaluate LVEF, diastolic function, and valvular disease
Limitations of BNP
BNP can be elevated for reasons unrelated to primary cardiac pathology. The following conditions should be considered when interpreting an elevated result:
- Advanced age (reference ranges increase with age)
- Renal impairment (reduced BNP clearance with declining eGFR)
- Atrial fibrillation
- ARNI use (angiotensin receptor-neprilysin inhibitors): NT-proBNP rises, but BNP may be suppressed
In low-RCRI patients, adding BNP is unlikely to reclassify risk or change management (JCS 2022). Routine BNP measurement in all preoperative patients is not supported by current evidence.
Basis for this approach
ESC 2022 Guidelines on Cardiovascular Assessment and Management of Patients Undergoing Non-cardiac Surgery (BNP/NT-proBNP measurement: Class IIa) / JCS 2022 Guidelines on Perioperative Cardiovascular Evaluation for Non-cardiac Surgery / VISION trial (Vascular events In noncardiac Surgery patIents cOhort evaluatioN)
Continue learning
Dyspnea on Stairs: Is Functional Capacity Really Adequate?
Patients often report that they are 'active' or 'walking regularly.' That does not mean they have adequate functional capacity. This case teaches how to move from symptom to functional limitation to perioperative decision.
Elevated BNP Before Surgery: A Signal, Not a Diagnosis
BNP 250 pg/mL. An elevated BNP does not diagnose heart failure. It signals that cardiac stress may be present. The key question is why it is elevated.
A Prior PCI Is Not the Whole Story: Assessing Coronary Disease Before Surgery
When a patient has a history of PCI, the first question is not about antiplatelet therapy. The first question is whether coronary artery disease remains stable today.
Apply this in practice
BNP elevated → enter BNP, RCRI, and functional capacity into the Navigator
Verify this decision in the tool →